Webinar | July 17, 2019

Mitigating Risk Through Product Characterization

In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.

  • Characterization of therapeutic antibodies
    • what, why, and when
    • Benefits of early use of PC approaches to understand your product
  • Complexities of monoclonal (mAbs) and their characterization
  • Approaches to characterization of mAb physico-chemical and structural attributes
  • Functional characterization of mAbs
access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

MilliporeSigma